Geneesmiddelen | Horizonscan geneesmiddelen

Masitinib

Benralizumab Dupilumab Tiotropium bromide Tralokinumab

Amoxicilline / omeprazol / rifabutin Cadazolid Eravacycline Liposomaal amikacine Meropenem / vaborbactam Omadacycline Ozenoxacine Recombinant vaccin voor meningokokken groep B

Atezolizumab Durvalumab / Tremelimumab Pembrolizumab Ramucirumab

Andexanet alfa Betrixaban Ciraparantag Vonicog alfa

Alicaforsen

Pouchitis Ulcerative colitis (UC)

Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue Lubiprostone Masitinib Remestemcel-L Rifaximin Tofacitinib

Brain cancer vaccine Depatuxizumab mafodotin

Abemaciclib Atezolizumab Fulvestrant Neratinib Olaparib Pembrolizumab

Ribociclib

Breast cancer, advanced metastatic, HR+ and HER2-, in combination with fulvestrant, postmenopausal women and men, 1L en 2L Breast cancer, advanced metastatic, HR+ and HER2-, in combination with tamoxifen and goserelin or a non-steroidal aromatase inhibitor (NSAI) and goserelin, premenopausal women.

Trastuzumab

Veliparib

Breast cancer; early-stage triple-negative - neoadjuvant therapy with carboplatin Breast cancer; HER2-negative metastatic or locally advanced unresectable BRCA-associated - first to third-line in combination with carboplatin and paclitaxel.

Fluticasone furoate / umeclidinium (bromide) / vilanterol (trifenatate) Glycopyrrolate / formoterol Mepolizumab

Avacopan Canakinumab Evolocumab Prasugrel Rivaroxaban Tocilizumab

Nivolumab

Tezacaftor / ivacaftor

Leuco-methylthioninium

Alzheimer’s disease, mild-to-moderate. Dementia, behavioural variant frontotemporal.

Dapagliflozine Ertugliflozin Ertugliflozin (L-pyroglutamic acid) / metformin (hydrochloride) Ertugliflozin (L-pyroglutamic acid) / sitagliptin (phosphate monohydrate) Exenatide Glibenclamide Semaglutide

Vigabatrin

Adalimumab Cenegermin

Ciclosporin

Keratoconjunctivitis sicca (or dry eye disease), moderate-to-severe and specifically in patients with atopic keratoconjunctivitis. Treatment of severe vernal keratoconjunctivitis in children from 4 years of age and adolescents.

Mercaptamine Pegpleranib Voretigene neparvovec

Ibrutinib

Damoctocog alfa pegol Emicizumab Rurioctocog alfa pegol Viable T-cells

Afatinib Durvalumab / Tremelimumab Pembrolizumab

Eptinezumab Erenumab Galcanezumab

Allogenic immunomodulatory progenitor cells Autologous stem cells Ularitide Valsartan / sacubitril

Romiplostim Ropeginterferon alfa-2b

Human fibrinogen / Human thrombin

Abaloparatide Cinacalcet Enclomifene (citrate) Pasireotide LAR Prasterone Recombinant parathyroid hormone

Atezolizumab Ipilimumab Sunitinib

Blinatumomab

Adults with minimal residual disease (MRD) positive B-cell precursor acute lymphoblastic leukaemia (ALL). Relapsed / Refractory Ph+ Adult Acute Lymphoblastic Leukemia (ALL). Relapsed / Refractory precursor-B Acute Lymphoblastic Leukemia (ALL) in children.

Bosutinib Cytarabine / daunorubicin (liposomaal) Dasatinib Gemtuzumab ozogamicin Idelalisib Inotuzumab ozogamicin Midostaurin Nilotinib Tisagenlecleucel Venetoclax in combinatie met rituximab

Nivolumab Regorafenib

Obeticholic acid

Alectinib Anamorelin

Atezolizumab

NSCLC non-squamous 1st line. Tecentriq is als monotherapie geïndiceerd voor de behandeling van volwassen patiënten met lokaal gevorderde of gemetastaseerde niet-kleincellige longkanker (NSCLC) na eerdere behandeling met chemotherapie. Patiënten met EGFR-activerende mutaties of ALK-positieve mutaties moeten ook doelgerichte behandeling hebben ontvangen voor ze Tecentriq krijgen.

Avelumab Brigatinib Durvalumab Durvalumab / Tremelimumab Osimertinib Pembrolizumab Rociletinib Rovalpituzumab tesirine Veliparib

Axicabtagene ciloleucel Brentuximab vedotin

Ibrutinib

Follicular lymphoma (FL), relapsed / refractory. Mantle cell lymphoma (MCL), 1L. Marginal zone lymphoma (MZL), relapsed / refractory. Non-germinal center B-cell-like (non-GCB) diffuse large B-cell lymphoma (DLBCL), 1L.

Obinutuzumab Tisagenlecleucel

Nintedanib Nivolumab

Asfotase alfa Burosumab Cerliponase alfa Chenodeoxycholzuur Cholic acid Cyclodextrine (Hydroxypropyl betadex) Ibiglustat Idursulfase-IT Levamisole (hydrochloride) Metreleptin Migalastat Neod001 Patiromer Pegvaliase Sebelipase alfa Sodium benzoate Sodium zirconium cyclosilicate Velmanase alfa Vestronidase alfa Volanesorsen (sodium)

Denosumab Pembrolizumab Plitidepsin

Biotin Cladribine Masitinib Ocrelizumab Ozanimod Siponimod

Botulinum A toxin

Lower limb spasticity (LLS), in adults post stroke or traumatic brain injury (TBI). Lower limb spasticity (LLS), post stroke.

Eculizumab Eteplirsen Idebenone Mexiletine HCl Nusinersen Valbenazine

Lutetium-177 Telotristat etiprate

Budesonide Forigerimod (Rigerimod) Icatibant Lesinurad / allopurinol

Benznidazole

Alpha-1-antitrypsin Mepolizumab

Botulinum A toxin CM-AT / CM-4612 Esketamine Patisiran

Niraparib (tosylate monohydrate) Olaparib Paclitaxel Rucaparib Veliparib

Olaparib

Pimavanserin

Abiraterone Olaparib Padeliporfin

Brexpiprazole Cariprazine (hydrochloride) Esketamine Lurasidone

Adalimumab Sirukumab Upadacitinib

Avelumab Binimetinib Encorafenib Nivolumab Pembrolizumab

Abatacept Adalimumab Baricitinib Certolizumab pegol Dupilumab Guselkumab Ixekizumab Nemolizumab Risankizumab Tildrakizumab Tofacitinib

Melatonin Pitolisant Tasimelteon

Atezolizumab Masitinib Pembrolizumab

Caplacizumab

Anacetrapib MABp1

Bictegravir / emtricitabine / tenofovir alafenamide fumaraat Darunavir / cobicistat / emtricitabine / tenofovir alafenamide Dolutegravir /rilpivirine Emtricitabine / tenofovir disproxil fumarate Glecaprevir / pibrentasvir Letermovir Peramivir Recombinant zoster vaccin Sofosbuvir / velpatasvir / voxilaprevir

Informatie over geneesmiddelen die in de nabije toekomst op de markt verwacht worden.

Published on 9 January 2018

ALS

Asthma

Bacterial infections

Bladder cancer

Blood clotting

Bowel diseases

Alicaforsen

Brain cancer

Breast cancer

Ribociclib

Veliparib

COPD

Cardiovascular diseases

Colon cancer

Cystic fibrosis

Dementia

Leuco-methylthioninium

Diabetes

Epilepsy

Eye disorders

Ciclosporin

Graft versus Host

Haemophilia

Head and neck cancer

Headache

Heart failure

Hematology other

Hemostasis

Hormonal disorders

Kidney cancer

Leukemia

Blinatumomab

Liver cancer

Liver diseases

Lung cancer

Atezolizumab

Lymphoma

Ibrutinib

Mesothelioma

Metabolic diseases

Multiple Myeloma

Multiple sclerosis

Muscular diseases

Botulinum A toxin

Neuroendocrine cancer

Other chronic immune diseases

Other infectious diseases

Other lung

Other neurological disorders

Ovarian cancer

Pancreatic cancer

Parkinson's

Prostate cancer

Psychiatry

Rheumatism

Skin cancer

Skin diseases

Sleep disorders

Stomach cancer

Thrombosis

Unknown

Viral infections

Service

About this site